Background: Infertility is customarily defined as the inability to conceive after 1 year of regular unprotected intercourse. The Practice Committee of the American Society for Reproductive Medicine (ASRM) has published guidelines for a standard infertility evaluation. It includes a semen analysis, assessment of ovulation, a hysterosalpingogram, and, if indicated, tests for ovarian reserve and laparoscopy. The aim of this study was to compare the possible changes in uterine artery doppler indices after the use of pentoxifylline and low dose aspirin in patients with unexplained fertility. Methods: This prospective comparative clinical study was conducted on patients age between 20 and 35 years old, body mass index (BMI) from 18 – 25 kg/m2, with unexplained infertility. Patients were divided into two equal groups: low dose aspirin group and pentoxifylline group. All patients were subjected to personal, husband, sexual and menstrual history taking, clinical examination, routine infertility investigations [Husband semen analysis, Hormonal investigation (FSH, LH, midluteal progesterone, prolactin, TSH)], hysterosalpingogram, laparoscope and transvaginal ultrasound. Results: There was no significant difference between both groups regarding age, BMI, occupation, residency, parity, type/duration of infertility, menstrual regularity/amount, dysmenorrhea, sexual intercourse frequency, using of lubricant or vaginal douching. There was no significant difference between the studied groups regarding FSH, LH, TSH, basal uterine artery RI and PI and S/D ratio at one and three months. Conclusions: In women with unexplained infertility, there was no significant difference between the effect of pentoxifylline and low dose aspirin on the uterine artery blood flow or Doppler indices (RI, PI and S/D ratio).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.